Literature DB >> 23754654

Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes.

.   

Abstract

BACKGROUND: The management of primary rectal cancer beyond total mesorectal excision planes (PRC-bTME) and recurrent rectal cancer (RRC) is challenging. There is global variation in standards and no guidelines exist. To achieve cure most patients require extended, multivisceral, exenterative surgery, beyond conventional total mesorectal excision planes. The aim of the Beyond TME Group was to achieve consensus on the definitions and principles of management, and to identify areas of research priority.
METHODS: Delphi methodology was used to achieve consensus. The Group consisted of invited experts from surgery, radiology, oncology and pathology. The process included two international dedicated discussion conferences, formal feedback, three rounds of editing and two rounds of anonymized web-based voting. Consensus was achieved with more than 80 per cent agreement; less than 80 per cent agreement indicated low consensus. During conferences held in September 2011 and March 2012, open discussion took place on areas in which there is a low level of consensus.
RESULTS: The final consensus document included 51 voted statements, making recommendations on ten key areas of PRC-bTME and RRC. Consensus agreement was achieved on the recommendations of 49 statements, with 34 achieving consensus in over 95 per cent. The lowest level of consensus obtained was 76 per cent. There was clear identification of the need for referral to a specialist multidisciplinary team for diagnosis, assessment and further management.
CONCLUSION: The consensus process has provided guidance for the management of patients with PRC-bTME or RRC, taking into account global variations in surgical techniques and technology. It has further identified areas of research priority.

Entities:  

Mesh:

Year:  2013        PMID: 23754654     DOI: 10.1002/bjs.9192

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  32 in total

1.  Factors associated with the location of local rectal cancer recurrence and predictors of survival.

Authors:  Peng Du; John P Burke; Wisam Khoury; Ian C Lavery; Ravi P Kiran; Feza H Remzi; David W Dietz
Journal:  Int J Colorectal Dis       Date:  2016-02-10       Impact factor: 2.571

Review 2.  How Should Imaging Direct/Orient Management of Rectal Cancer?

Authors:  Jemma Bhoday; Svetlana Balyasnikova; Anita Wale; Gina Brown
Journal:  Clin Colon Rectal Surg       Date:  2017-11-27

3.  Systemic Chemotherapy as Salvage Treatment for Locally Advanced Rectal Cancer Patients Who Fail to Respond to Standard Neoadjuvant Chemoradiotherapy.

Authors:  Francesco Sclafani; Gina Brown; David Cunningham; Sheela Rao; Paris Tekkis; Diana Tait; Federica Morano; Chiara Baratelli; Eleftheria Kalaitzaki; Shahnawaz Rasheed; David Watkins; Naureen Starling; Andrew Wotherspoon; Ian Chau
Journal:  Oncologist       Date:  2017-05-05

4.  Variations of the renal function parameters in rectal cancer patients with a defunctioning loop ileostomy.

Authors:  Dragos Viorel Scripcariu; Dimitrie Siriopol; Mihaela Moscalu; Viorel Scripcariu
Journal:  Int Urol Nephrol       Date:  2018-07-04       Impact factor: 2.370

Review 5.  Surgery for Locally Advanced T4 Rectal Cancer: Strategies and Techniques.

Authors:  Ramzi M Helewa; Jason Park
Journal:  Clin Colon Rectal Surg       Date:  2016-06

6.  Outcomes and prognostic factors of multimodality treatment for locally recurrent rectal cancer with curative intent.

Authors:  Thomas G Bird; Samuel Y Ngan; Julie Chu; René Kroon; Andrew C Lynch; Alexander G Heriot
Journal:  Int J Colorectal Dis       Date:  2018-02-21       Impact factor: 2.571

Review 7.  Surgery for rectal cancer-what is on the horizon?

Authors:  Thomas A Vermeer; Ricardo G Orsini; Harm J T Rutten
Journal:  Curr Oncol Rep       Date:  2014-03       Impact factor: 5.075

8.  Surgery for Locally Advanced GIT Cancers Has Potentially Good Postoperative Outcomes in a Tertiary Hospital.

Authors:  Anwar Tawfik Amin; Ahmed A S Salem; Abeer Ibrahim
Journal:  J Gastrointest Cancer       Date:  2020-03

9.  The significance of extramural venous invasion in R1 positive rectal cancer.

Authors:  N M Ormsby; H N Bermingham; H M Joshi; M Chadwick; A Samad; D Maitra; M Scott; S Kelly; K Whitmarsh; R Rajaganeshan
Journal:  Int J Colorectal Dis       Date:  2016-10-01       Impact factor: 2.571

10.  Impact of multimodal therapy in locally recurrent rectal cancer.

Authors:  Y N You; J M Skibber; C-Y Hu; C H Crane; P Das; E S Kopetz; C Eng; B W Feig; M A Rodriguez-Bigas; G J Chang
Journal:  Br J Surg       Date:  2016-03-02       Impact factor: 6.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.